Regeneron Pharmaceuticals (REGN) discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company answered the pandemic bell and delivered vaccine and monoclonal antibody treatments for COVID patients. What lies ahead for this innovative health solutions enterprise? #Shorts
source
